About Company
AlphaLife Sciences is transforming life sciences through AuroraPrime, our premier AI-driven content
authoring platform. Trusted by leading global pharmaceutical companies, our advanced solutions
automate and streamline regulatory and medical writing, accelerating drug development and ensuring
precision at every step.
Backed by industry leaders including Microsoft’s Pegasus Program, Google, NVIDIA, Johnson &
Johnson Innovation - JLABS, and Veeva’s AI Program, we combine cutting-edge technology with deep
domain expertise. As active contributors to industry organizations like CDISC and TransCelerate, we
lead innovation and set new standards in life sciences.
Partner with AlphaLife Sciences to unlock the full potential of AI, dramatically enhance efficiency,
and drive unparalleled success in your pharmaceutical initiatives.
Mission
At AlphaLife Sciences, our mission is to be the leading generative AI-powered digital solution
enabler for life sciences, driving productivity and quality throughout the drug lifecycle by
transforming medical and regulatory writing through intelligent automation and digital innovation.
Our Vision
Revolutionizing Life Sciences with Generative AI:
Accelerating Faster, Affordable Drug Development.
Brand Story
In 2020, a group of senior technology and product experts from Google and Verily decided to start a
business and delve into the intelligent digitalization of life science clinical research. With the
goal of building a SaaS platform for life science and consumer health fields through world-leading
computer technology, AlphaLife Sciences was officially established in August 2020. With the vision
of "Use technology to advance innovation in life science and consumer health. Faster, more
accessible and evidence-based," the AlphaLife team quickly grew and attracted many technology
talents from leading global IT companies and senior industry experts from the life sciences field.
With the gradual launch of AlphaLife's innovative products, more and more leading life science
innovation and development companies, as well as ecosystem partners, choose AlphaLife, collaborate
in multiple ways, and jointly explore the future of intelligent digitalization in clinical research.
